Real world eligibility and prognostic relevance for sacubitril/valsartan in unselected heart failure outpatients: data from an Italian registry (IN-HF outcome)

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Chronic heart failure – treatment Treatment ESC Premium Access ESC Congress 2018

ESC 365 is supported by

ESC 365 is supported by